Posts

Featured Article

Are Vaccines Safe

By MDA Staff | March 4, 2021
Blog Post

Clinical Trial Alert: Phase 3 Study of Zilucoplan in Individuals With Generalized Myasthenia Gravis

By MDA Staff | March 2, 2021
Blog Post

FDA Approves Sarepta Therapeutics’ Amondys 45 for Treatment of DMD Amenable to Skipping Exon 45

By Sujatha Gurunathan | February 25, 2021
Blog Post

Clinical Trial Alert: Phase 3 Study of Rozanolixizumab in Individuals With Generalized Myasthenia Gravis

By MDA Staff | February 23, 2021
Featured Article

Plan for a Bright Future

By Karen Doss Bowman | February 23, 2021
Featured Article

New Research Channels for Myotonia Congenita

By MDA Staff | February 23, 2021
Mindy Henderson speaking to a group
Featured Article

Disability or Superpower

By Mindy Henderson | February 23, 2021
Featured Article

Creativity and Adaptability

By MDA Staff | February 23, 2021
Featured Article

Affordable Accessibility at Home or On the Go

By Elizabeth Millard | February 23, 2021
Blog Post

MDA Welcomes Dr. Don Wood as its New President and CEO

By Nancy Intrator | February 16, 2021